Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
Cancer, 05/21/2012Katz MHG et al.
Radiographic downstaging was rare after neoadjuvant therapy, and Response Evaluation Criteria in Solid Tumors (RECIST) response was not an effective treatment endpoint for patients with borderline resectable pancreatic cancer. The authors concluded that these patients should undergo pancreatectomy after initial therapy in the absence of metastases.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.